Subcommittee F04.16 on Biocompatibility Test Methods
Matching Standards Under the Jurisdiction of F04.16 by Status
- F1983-23 Standard Practice for Assessment of Selected Tissue Effects of Absorbable Biomaterials for Implant Applications
- F619-20 Standard Practice for Extraction of Materials Used in Medical Devices
- F719-20e1 Standard Practice for Testing Materials in Rabbits for Primary Skin Irritation
- F720-24 Standard Test Method for Testing Guinea Pigs for Contact Allergens: Guinea Pig Maximization Test
- -See also WK85069 proposed Revision
- F748-25 Standard Practice for Selecting Biological Test Methods for Materials and Devices
- -See also WK76724 proposed Revision
- F749-20 Standard Practice for Evaluating Material Extracts by Intracutaneous Injection in the Rabbit
- F750-20 Standard Practice for Evaluating Acute Systemic Toxicity of Material Extracts by Systemic Injection in the Mouse
- F763-22 Standard Practice for Short-Term Intramuscular Screening of Implantable Medical Device Materials
- F813-20 Standard Practice for Direct Contact Cell Culture Evaluation of Materials for Medical Devices
- F895-25 Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity
- -See also WK76726 proposed Revision
- F981-23 Standard Practice for Assessment of Muscle and Bone Tissue Responses to Long-Term Implantable Materials Used in Medical Devices
- F1408-20a Standard Practice for Subcutaneous Screening Test for Implant Materials
- F1903-18 Standard Practice for Testing for Cellular Responses to Particles
in vitro - -See also WK91753 proposed Revision
- F1904-23 Standard Guide for Testing the Biological Responses to Medical Device Particulate Debris and Degradation Products
in vivo - F2147-01(2025) Standard Practice for Guinea Pig: Split Adjuvant and Closed Patch Testing for Contact Allergens
- -See also WK92588 proposed Reapproval
- E1262-24 Standard Guide for Performance of Chinese Hamster Ovary Cell/Hypoxanthine Guanine Phosphoribosyl Transferase Gene Mutation Assay
- -See also WK90571 proposed Revision
- F1439-24 Standard Guide for Performance of Lifetime Bioassay for the Tumorigenic Potential of Implant Materials
- -See also WK90583 proposed Revision
- F1877-24 Standard Practice for Characterization of Particles
- -See also WK76967 proposed Revision
- F1984-25 Standard Practice for Testing for Whole Complement Activation in Serum by Solid Materials
- -See also WK90775 proposed Revision
- F2148-18 Standard Practice for Evaluation of Delayed Contact Hypersensitivity Using the Murine Local Lymph Node Assay (LLNA)
- -See also WK91064 proposed Revision
- F2382-24 Standard Test Method for Assessment of Circulating Blood-Contacting Medical Device Materials on Partial Thromboplastin Time (PTT)
- -See also WK87253 proposed Revision
- F2901-19 Standard Guide for Selecting Tests to Evaluate Potential Neurotoxicity of Medical Devices
- F756-17 Standard Practice for Assessment of Hemolytic Properties of Materials
- F2808-23 Standard Test Method for Performing Behind-the-Knee (BTK) Test for Evaluating Skin Irritation Response to Products and Materials That Come Into Repeated or Extended Contact with Skin
- F2888-19 Standard Practice for Platelet Leukocyte Count—An
In-Vitro Measure for Hemocompatibility Assessment of Cardiovascular Materials
- F2151-01 Standard Practice for Assessment of White Blood Cell Morphology After Contact with Materials (Withdrawn 2007)
- E1202-87(2008) Standard Guide for Development of Micronucleus Assay Standards (Withdrawn 2013)
- E1263 Standard Guide for Conduct of Micronucleus Assays in Mammalian Bone Marrow Erythrocytes (Withdrawn 2015)
- E1263-97(2008) Standard Guide for Conduct of Micronucleus Assays in Mammalian Bone Marrow Erythrocytes (Withdrawn 2015)
- E1280-97(2008) Standard Guide for Performing the Mouse Lymphoma Assay for Mammalian Cell Mutagenicity (Withdrawn 2015)
- E1398-91(2008) Standard Practice for In Vivo Rat Hepatocyte DNA Repair Assay (Withdrawn 2014)
- F1905-98(2003) Standard Practice for Selecting Tests for Determining the Propensity of Materials to Cause Immunotoxicity (Withdrawn 2011)
- F1906-98(2003) Standard Practice for Evaluation of Immune Responses In Biocompatibility Testing Using ELISA Tests, Lymphocyte, Proliferation, and Cell Migration (Withdrawn 2011)
- F2065-00(2010) Standard Practice for Testing for Alternative Pathway Complement Activation in Serum by Solid Materials (Withdrawn 2016)
- E1280 Standard Guide for Performing the Mouse Lymphoma Assay for Mammalian Cell Mutagenicity (Withdrawn 2015)
- F2065 Standard Practice for Testing for Alternative Pathway Complement Activation in Serum by Solid Materials (Withdrawn 2016)
- F2567-06(2010) Standard Practice for Testing for Classical Pathway Complement Activation in Serum by Solid Materials (Withdrawn 2016)
- E1397-91(2008) Standard Practice for In Vitro Rat Hepatocyte DNA Repair Assay (Withdrawn 2014)
- F2567 Standard Practice for Testing for Classical Pathway Complement Activation in Serum by Solid Materials (Withdrawn 2016)
- F1027-86(2017) Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices (Withdrawn 2023)